“…The isolated compounds ( 1–11 ) were evaluated for cytotoxic activity against human tumor cell lines A549 (non-small-cell lung cancer cells), HCT116 (human colon cancer cells), MDA-MB-231 (human breast cancer cells), and HepG2 (human hepatocellular carcinoma cells) in vitro (Table 3). 39 The results showed that compounds 1 and 2 displayed appreciable cytotoxic activity against A549 and HCT116 cell lines with IC 50 values of 6.40–7.76 μM, whereas compounds 9 and 10 only exhibited potent inhibition against A549, HCT116 and HepG2 cells with IC 50 values of 9.46–15.07 μM. Doxorubicin was employed as the positive control and its IC 50 values against A549, HCT116, MDA-MB-231 and HepG2 cells were 0.18 ± 0.004, 0.07 ± 0.001, 0.59 ± 0.010 and 0.06 ± 0.001 μM, respectively.…”